Comparing Oncology Pharma (OTCMKTS:ONPH) and Zenvia (NASDAQ:ZENV)

Oncology Pharma (OTCMKTS:ONPHGet Rating) and Zenvia (NASDAQ:ZENVGet Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.


This table compares Oncology Pharma and Zenvia’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Oncology Pharma N/A N/A N/A
Zenvia -5.93% -4.49% -2.78%

Institutional and Insider Ownership

55.0% of Zenvia shares are held by institutional investors. 18.0% of Oncology Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Oncology Pharma and Zenvia’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Oncology Pharma N/A N/A N/A N/A N/A
Zenvia $113.49 million 1.61 -$8.27 million ($0.26) -17.08

Oncology Pharma has higher earnings, but lower revenue than Zenvia.

Analyst Ratings

This is a summary of current ratings and recommmendations for Oncology Pharma and Zenvia, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Pharma 0 0 0 0 N/A
Zenvia 0 0 3 0 3.00

Zenvia has a consensus target price of $21.15, suggesting a potential upside of 376.35%. Given Zenvia’s higher possible upside, analysts clearly believe Zenvia is more favorable than Oncology Pharma.

Oncology Pharma Company Profile (Get Rating)

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Zenvia Company Profile (Get Rating)

Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.

Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with's FREE daily email newsletter.